Renaissance Technologies’s Athira Pharma ATHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$72.8K Buy
241,000
+22,000
+10% +$6.64K ﹤0.01% 3345
2025
Q1
$62.4K Buy
219,000
+11,700
+6% +$3.33K ﹤0.01% 3265
2024
Q4
$122K Sell
207,300
-245,487
-54% -$144K ﹤0.01% 3258
2024
Q3
$202K Buy
452,787
+181,299
+67% +$80.9K ﹤0.01% 3125
2024
Q2
$719K Buy
271,488
+9,164
+3% +$24.3K ﹤0.01% 2507
2024
Q1
$719K Sell
262,324
-3,076
-1% -$8.43K ﹤0.01% 2686
2023
Q4
$645K Sell
265,400
-17,500
-6% -$42.5K ﹤0.01% 2658
2023
Q3
$571K Sell
282,900
-155,900
-36% -$315K ﹤0.01% 2647
2023
Q2
$1.29M Buy
438,800
+126,935
+41% +$374K ﹤0.01% 2303
2023
Q1
$780K Buy
311,865
+229,765
+280% +$575K ﹤0.01% 2632
2022
Q4
$260K Sell
82,100
-152,903
-65% -$484K ﹤0.01% 3294
2022
Q3
$698K Buy
+235,003
New +$698K ﹤0.01% 2718
2022
Q2
Sell
-37,400
Closed -$505K 4209
2022
Q1
$505K Sell
37,400
-76,400
-67% -$1.03M ﹤0.01% 3185
2021
Q4
$1.48M Buy
113,800
+61,067
+116% +$796K ﹤0.01% 2371
2021
Q3
$495K Buy
+52,733
New +$495K ﹤0.01% 2896